End Stage Kidney Disease
Nephrology
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Outset MedicalSAN JOSE, CA
1 programIntermittent Renal Replacement Therapy using the Tablo Hemodialysis SystemN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Hansa BiopharmaIdeS
Outset MedicalIntermittent Renal Replacement Therapy using the Tablo Hemodialysis System
Clinical Trials (2)
Total enrollment: 458 patients across 2 trials
Study to Evaluate the Safety, Tolerability, Efficacy and PK of IdeS in Kidney Transplantation
Start: Jun 2015Est. completion: Oct 2016
Phase 2Completed
Comparative Outcome Measures of Patients Receiving Acute Renal ThErapy Study
Start: May 2021Est. completion: Jun 2022458 patients
N/ACompleted
Related Jobs in Nephrology
Thesis work, 60 credits – Establishing In Vitro Models of Mitochondrial Dysfunction in Acute Kidney Injury for Preclinical Drug Discovery
AstraZeneca
Sweden - Gothenburg
6d ago
Associate Director – Nephrology Market Access Strategy
Biogen
Cambridge, MA
1w ago
$164K - $226K/yr
Director, Strategy & Operations-Nephrology Franchise
Biogen
Cambridge, MA
1w ago
$195K - $269K/yr
Medical Science Liaison, CardioRenal - Portland, OR
AstraZeneca
Portland - OR, US
1w ago
Vice President, Head of Renal Sales
Novartis
Field Non-Sales (USA)
1w ago
$274K - $510K/yr
Area Sales Manager (Florida Region)
Outset Medical
Florida Region
1w ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space